Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agnico Eagle Mines Ltd (AEM) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Agnico Eagle Mines LtdTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Agnico Eagle Mines Ltd vs Citius Pharmaceuticals Inc — how do they compare? Agnico Eagle Mines Ltd trades at $184.84 (market cap $92.01B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Agnico Eagle Mines Ltd is far larger — about 4598.2× Citius Pharmaceuticals Inc's market cap, and Agnico Eagle Mines Ltd pays a 0.99% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AEMCTXR
Market Cap
$92.01B$20.01M
Sector
Basic MaterialsHealth
52-Week High
$252.19$1.82
52-Week Low
$130.23$0.48
Enterprise Value
$88.85B$16.23M
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agnico Eagle Mines Ltd

No Aura AI signal available yet.

Citius Pharmaceuticals Inc

CTXR is trading at $0.68, up 6.28% today, with a bullish technical signal from moving averages. The company shows strong commercial momentum with LYMPHIR cancer treatment revenue reaching $5.6 million in H1 2026, though it remains unprofitable with a -823% net margin. Analyst consensus is strongly bullish with 83% buy ratings.

The outlook depends on LYMPHIR's commercial success offsetting deep losses. Near-term catalysts include expanded market access and combination therapy data, but high cash burn and execution risks require monitoring. The stock offers speculative growth potential in oncology but carries significant financial risk.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Agnico Eagle Mines Ltd

Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.

Read more on AEM

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR